422 related articles for article (PubMed ID: 8678620)
1. Barrett's esophagus with high-grade dysplasia. An indication for prophylactic esophagectomy.
Heitmiller RF; Redmond M; Hamilton SR
Ann Surg; 1996 Jul; 224(1):66-71. PubMed ID: 8678620
[TBL] [Abstract][Full Text] [Related]
2. Barrett's esophagus with high grade dysplasia: surgical results and long-term outcome--an update.
Tseng EE; Wu TT; Yeo CJ; Heitmiller RF
J Gastrointest Surg; 2003 Feb; 7(2):164-70; discussion 170-1. PubMed ID: 12600440
[TBL] [Abstract][Full Text] [Related]
3. The rationale for esophagectomy as the optimal therapy for Barrett's esophagus with high-grade dysplasia.
Edwards MJ; Gable DR; Lentsch AB; Richardson JD
Ann Surg; 1996 May; 223(5):585-9; discussion 589-91. PubMed ID: 8651749
[TBL] [Abstract][Full Text] [Related]
4. The management of high grade dysplasia and early cancer in Barrett's esophagus. A multidisciplinary problem.
Rusch VW; Levine DS; Haggitt R; Reid BJ
Cancer; 1994 Aug; 74(4):1225-9. PubMed ID: 8055442
[TBL] [Abstract][Full Text] [Related]
5. Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma--an American single-center experience.
Chennat J; Konda VJ; Ross AS; de Tejada AH; Noffsinger A; Hart J; Lin S; Ferguson MK; Posner MC; Waxman I
Am J Gastroenterol; 2009 Nov; 104(11):2684-92. PubMed ID: 19690526
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcome of esophagectomy for high-grade dysplasia or cancer found during surveillance for Barrett's esophagus.
Chang LC; Oelschlager BK; Quiroga E; Parra JD; Mulligan M; Wood DE; Pellegrini CA
J Gastrointest Surg; 2006 Mar; 10(3):341-6. PubMed ID: 16504878
[TBL] [Abstract][Full Text] [Related]
7. EUS followed by EMR for staging of high-grade dysplasia and early cancer in Barrett's esophagus.
Larghi A; Lightdale CJ; Memeo L; Bhagat G; Okpara N; Rotterdam H
Gastrointest Endosc; 2005 Jul; 62(1):16-23. PubMed ID: 15990814
[TBL] [Abstract][Full Text] [Related]
8. Risk of malignant progression in Barrett's esophagus indefinite for dysplasia.
Ma M; Shroff S; Feldman M; DeMarshall M; Price C; Tierney A; Falk GW
Dis Esophagus; 2017 Mar; 30(3):1-5. PubMed ID: 28184470
[TBL] [Abstract][Full Text] [Related]
9. Barrett's esophagus, high-grade dysplasia, and early adenocarcinoma: a pathological study.
Cameron AJ; Carpenter HA
Am J Gastroenterol; 1997 Apr; 92(4):586-91. PubMed ID: 9128304
[TBL] [Abstract][Full Text] [Related]
10. Surgical management of Barrett's esophagus.
Clark GW; DeMeester TR
Ann Chir Gynaecol; 1995; 84(2):139-44. PubMed ID: 7574371
[TBL] [Abstract][Full Text] [Related]
11. Treatment of Barrett's esophagus with high-grade dysplasia.
McAllaster JD; Buckles D; Al-Kasspooles M
Expert Rev Anticancer Ther; 2009 Mar; 9(3):303-16. PubMed ID: 19275509
[TBL] [Abstract][Full Text] [Related]
12. Long-term survival after esophagectomy for Barrett's adenocarcinoma in endoscopically surveyed and nonsurveyed patients.
Ferguson MK; Durkin A
J Gastrointest Surg; 2002; 6(1):29-35; discussion 36. PubMed ID: 11986015
[TBL] [Abstract][Full Text] [Related]
13. Surgical treatment of esophageal high-grade dysplasia.
Reed MF; Tolis G; Edil BH; Allan JS; Donahue DM; Gaissert HA; Moncure AC; Wain JC; Wright CD; Mathisen DJ
Ann Thorac Surg; 2005 Apr; 79(4):1110-5; discussion 1110-5. PubMed ID: 15797034
[TBL] [Abstract][Full Text] [Related]
14. Predictive factors of coexisting cancer in Barrett's high-grade dysplasia.
Tharavej C; Hagen JA; Peters JH; Portale G; Lipham J; DeMeester SR; Bremner CG; DeMeester TR
Surg Endosc; 2006 Mar; 20(3):439-43. PubMed ID: 16437272
[TBL] [Abstract][Full Text] [Related]
15. Eliminating a need for esophagectomy: endoscopic treatment of Barrett esophagus with early esophageal neoplasia.
Lada MJ; Watson TJ; Shakoor A; Nieman DR; Han M; Tschoner A; Peyre CG; Jones CE; Peters JH
Semin Thorac Cardiovasc Surg; 2014; 26(4):274-84. PubMed ID: 25837538
[TBL] [Abstract][Full Text] [Related]
16. Prospective multivariate analysis of clinical, endoscopic, and histological factors predictive of the development of Barrett's multifocal high-grade dysplasia or adenocarcinoma.
Weston AP; Badr AS; Hassanein RS
Am J Gastroenterol; 1999 Dec; 94(12):3413-9. PubMed ID: 10606296
[TBL] [Abstract][Full Text] [Related]
17. Oesophagectomy remains the gold standard for treatment of high-grade dysplasia in Barrett's oesophagus.
Sujendran V; Sica G; Warren B; Maynard N
Eur J Cardiothorac Surg; 2005 Nov; 28(5):763-6. PubMed ID: 16188449
[TBL] [Abstract][Full Text] [Related]
18. Endoscopic Treatment of Early Barrett's Adenocarcinoma and Dysplasia: Focus on Submucosal Cancer.
Frei N; Frei R; Semadeni GM; Jochum W; Brand S; Borovicka J
Digestion; 2019; 99(4):293-300. PubMed ID: 30176662
[TBL] [Abstract][Full Text] [Related]
19. Long-term follow-up of complete Barrett's eradication endoscopic mucosal resection (CBE-EMR) for the treatment of high grade dysplasia and intramucosal carcinoma.
Larghi A; Lightdale CJ; Ross AS; Fedi P; Hart J; Rotterdam H; Noffsinger A; Memeo L; Bhagat G; Waxman I
Endoscopy; 2007 Dec; 39(12):1086-91. PubMed ID: 17701854
[TBL] [Abstract][Full Text] [Related]
20. Barrett's esophagus with high-grade dysplasia: an indication for esophagectomy?
Pera M; Trastek VF; Carpenter HA; Allen MS; Deschamps C; Pairolero PC
Ann Thorac Surg; 1992 Aug; 54(2):199-204. PubMed ID: 1637206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]